Breast Cancer Prognosis Prediction and Immune Pathway Molecular Analysis Based on Mitochondria-Related Genes

Figure 1

Screening of mitochondria-related genes and establishment of a risk score model. (a) Differential (increased or reduced) mitochondria-related gene expression in the hazard group compared with that in the normal group. (b) Error rates of randomly generated trees (upper panel). Variable relative importance of the four selected mitochondria-related genes. (c) LASSO analysis: partial likelihood deviance values were plotted against log (λ) (upper panel). The relative abundance of the selected genes varies with the risk score.

(a)

(b)

(c)